Market Access

Realizing Opportunities in Pharma and MedTech

Why choose Alira Health?

As your partner, we’ll work closely with you to uncover opportunities across the pharma industry, accelerate innovation, and deliver tomorrow’s standard of care. You’ll benefit from our:

  • Objective analysis

    Objective analysis of complex therapeutic areas, markets, pricing, and reimbursement landscapes

  • Industry expertise

    Extensive expertise in market access, pricing, health economics, and real-world evidence

  • Strategic consulting

    to define growth initiatives and accelerate market penetration. Learn more

  • An integrated team approach

    Our collaborative team works in partnership with clients, providing frequent, transparent and effective communication

  • Quality data

    High-quality outputs, substantiated by credible and established sources

  • Tailored solutions

    Our team works hard to get a clear understanding of your objectives, and designs solutions with your goal in mind

Global expertise in healthcare and life sciences

Alira Health’s market access team helps clients demonstrate value, optimize patient access, and realize the commercial opportunity for their healthcare and life sciences innovations.

Working together to transform healthcare

Whether you need to understand which asset best aligns with your long-term strategy, which new market or therapeutic area to explore, or how to expand into another sector, we are ready to help you lead the way.

Contact us
Jean-François Ricci
Jean-François Ricci
Executive Vice President, Global Market Access
Our strong client partnerships allow us to deliver in-depth, customized strategies and access solutions—all designed to maximize product value across its full lifecycle.

Related News

Market Access
Events July 11, 2021
Event: MTAA Value Based Procurement Webinar & Conference
Sign up for Alira Health's very own, Richard Charter's exclusive webinar on value-based procurement.
Digital Health Market Access
Publications April 20, 2021
Health Economics Evaluation and Value Proposition for an Antimicrobial Medical Device in the U.S. Market
A health economics evaluation assists companies during product development to better understand the product's impact across the ecosystem and position it appropriately.
Market Access MedTech
Multimedia February 26, 2021
Pricing in MedTech: Disentangling the Roles of Payers, DRGs, and Procurement
Join host Kenny Carberry, Associate Director of Clinical Development, Dan Legg, former Director of Clinical Sourcing at Guy’s & St Thomas at the St Thomas Hospital in London and CEO(...)
Market Access MedTech
Publications December 5, 2020
Critical Success Factors in Market Access
Today’s MedTech market is more concentrated than ever, with critical factors that need to be examined to advance a new product.
Market Access Pharma
Multimedia November 2, 2020
WHO Guideline: Summary of Recommendations on Pharmaceutical Pricing Policies
The WHO recently launched a series of recommendations on pharmaceutical pricing policies to help countries make medicines more affordable for the global population and lessen the burden(...)
Advanced Analytics Market Access Pharma
Publications November 1, 2020
Our Parallel Trade Expertise
Alira Health is proud to announce our new collaboration with Mark Inigo Jones, an industry leader in European parallel trade of pharmaceutical products.
Market Access MedTech
News August 29, 2020
Alira Health Starts a New Collaboration with Mark Inigo Jones on Parallel Trade Management
We are pleased to announce a new collaboration with Mark Inigo Jones, an industry leader in European parallel trade of pharmaceutical products.

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.